within Pharmacolibrary.Drugs.ATC.J;

model J01RA11
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 25 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.12,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>This fixed-dose combination contains ciprofloxacin, a fluoroquinolone antibiotic, and tinidazole, a nitroimidazole antimicrobial. It is used for the treatment of a variety of mixed infections, especially those involving both aerobic and anaerobic bacteria, such as complicated urinary tract infections, gynecological, or gastrointestinal infections. The combination is approved and is commonly used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated based on data from individual drugs administered orally in healthy adults, as no published population PK data for the fixed combination product were found.</p><h4>References</h4><ol><li><p>El-Kimary, EI, et al., &amp; Abdel Moneim, MM (2018). Sensitive inexpensive chromatographic determination of an antimicrobial combination in human plasma and its pharmacokinetic application. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 1097-1098 94â€“100. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2018.09.008&quot;>10.1016/j.jchromb.2018.09.008</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30218919/&quot;>https://pubmed.ncbi.nlm.nih.gov/30218919</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01RA11;
